Author Summary
Integrins in Pulmonary Fibrosis: Therapeutic Targets and Trials
Pulmonary fibrosis (PF) is the end stage of several interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis. Progressive scarring destroys lung architecture, impairs gas exchange, and leads to respiratory failure. Outcomes […]